Iminopyrimidine nmda nr2b receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 239/42 (2006.01) A61K 31/505 (2006.01) A61K 31/517 (2006.01) A61K 31/519 (2006.01) C07D 239/70 (2006.01) C07D 471/04 (2006.01) C07D 487/00 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2412640

Compounds described by the chemical structural formula (I) or a pharmaceutically acceptable salt thereof, are useful in the treatment of pain, migraine, depression, anxiety, schizophrenia, Parkinson's disease, stroke, and in the treatment of neuropathies including postherpetic neuralgia, central pain from spinal cord injury, and phantom limb pain.

L'invention concerne des composés représentés par la formule structurale chimique (I) ou un sel pharmaceutiquement acceptable desdits composés, qui sont utilisés dans le traitement de la douleur, de la migraine, de la dépression, de l'anxiété, de la schizophrénie, de la maladie de Parkinson, des accidents vasculaires cérébraux ainsi que dans le traitement des neuropathies, notamment l'algie post-zotérienne, les douleurs centrales liées à une lésion de moelle épinière et la douleur du membre fantôme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Iminopyrimidine nmda nr2b receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Iminopyrimidine nmda nr2b receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iminopyrimidine nmda nr2b receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1645446

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.